Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Duvuru Geetha

Showing results (111-120 of 146) with videos related to

Pageof 15
Sort By:
American Journal of Nephrology|November 26, 2018
Predictors of Renal Outcomes in Sclerotic Class Anti-Neutrophil Cytoplasmic Antibody GlomerulonephritisSteven Menez, Zdenka Hruskova, Jennifer Scott, et al.
American Journal of Nephrology|June 6, 2015
Treatment of severe renal disease in ANCA positive and negative small vessel vasculitis with rituximabShivani Shah, Zdenka Hruskova, Marten Segelmark, et al.
Kidney International Reports|August 15, 2025
Treatment With Avacopan in ANCA-Associated Vasculitis With Kidney InvolvementDuvuru Geetha, Frank B Cortazar, Annette Bruchfeld, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 25, 2025
Cardiovascular Involvement in ANCA-associated VasculitisAhmad Sarmad, Zohreh Gholizadeh Ghozloujeh, Paul E Hanna, et al.
Journal of Nephrology|May 20, 2015
Rituximab for treatment of severe renal disease in ANCA associated vasculitisDuvuru Geetha, Zdenka Hruskova, Marten Segelmark, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 1, 2025
Longitudinal Trajectories of Kidney Function in Patients with Severe ANCA-Associated VasculitisJennifer S Hanberg, Yuqing Zhang, Andreas Kronbichler, et al.
Autoimmunity Reviews|October 31, 2021
The COVID-19 pandemic and ANCA-associated vasculitis - reports from the EUVAS meeting and EUVAS education forumAndreas Kronbichler, Duvuru Geetha, Rona M Smith, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 4, 2021
Disease Flare and Reactogenicity in Patients With Rheumatic and Musculoskeletal Diseases Following Two-Dose SARS-CoV-2 Messenger RNA VaccinationCaoilfhionn M Connolly, Jake A Ruddy, Brian J Boyarsky, et al.
Rheumatology (Oxford, England)|March 4, 2025
Efficacy and safety of avacopan in patients aged 65 years and older with ANCA-associated vasculitis: a post hoc analysis of data from the ADVOCATE trialDuvuru Geetha, Christian Pagnoux, Sebastian E Sattui, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 15, 2021
Induction and maintenance of remission with mycophenolate mofetil in ANCA-associated vasculitis: a systematic review and meta-analysisAlvise Berti, Mouaz Alsawas, Tabinda Jawaid, et al.
Pageof 15

Showing results (111-120 of 146) with videos related to

Sort By:
Pageof 15
American Journal of Nephrology|November 26, 2018
Predictors of Renal Outcomes in Sclerotic Class Anti-Neutrophil Cytoplasmic Antibody GlomerulonephritisSteven Menez, Zdenka Hruskova, Jennifer Scott, et al.
American Journal of Nephrology|June 6, 2015
Treatment of severe renal disease in ANCA positive and negative small vessel vasculitis with rituximabShivani Shah, Zdenka Hruskova, Marten Segelmark, et al.
Kidney International Reports|August 15, 2025
Treatment With Avacopan in ANCA-Associated Vasculitis With Kidney InvolvementDuvuru Geetha, Frank B Cortazar, Annette Bruchfeld, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 25, 2025
Cardiovascular Involvement in ANCA-associated VasculitisAhmad Sarmad, Zohreh Gholizadeh Ghozloujeh, Paul E Hanna, et al.
Journal of Nephrology|May 20, 2015
Rituximab for treatment of severe renal disease in ANCA associated vasculitisDuvuru Geetha, Zdenka Hruskova, Marten Segelmark, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 1, 2025
Longitudinal Trajectories of Kidney Function in Patients with Severe ANCA-Associated VasculitisJennifer S Hanberg, Yuqing Zhang, Andreas Kronbichler, et al.
Autoimmunity Reviews|October 31, 2021
The COVID-19 pandemic and ANCA-associated vasculitis - reports from the EUVAS meeting and EUVAS education forumAndreas Kronbichler, Duvuru Geetha, Rona M Smith, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 4, 2021
Disease Flare and Reactogenicity in Patients With Rheumatic and Musculoskeletal Diseases Following Two-Dose SARS-CoV-2 Messenger RNA VaccinationCaoilfhionn M Connolly, Jake A Ruddy, Brian J Boyarsky, et al.
Rheumatology (Oxford, England)|March 4, 2025
Efficacy and safety of avacopan in patients aged 65 years and older with ANCA-associated vasculitis: a post hoc analysis of data from the ADVOCATE trialDuvuru Geetha, Christian Pagnoux, Sebastian E Sattui, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 15, 2021
Induction and maintenance of remission with mycophenolate mofetil in ANCA-associated vasculitis: a systematic review and meta-analysisAlvise Berti, Mouaz Alsawas, Tabinda Jawaid, et al.
Pageof 15